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فعالية ضماد هيمكون لألسنان مقابل الطريقة التقليدية 
املتبعة يف ختثر الدم يف 40 مريضا يتناولون األدوية 
املضادة للصفيحات عن طريق الفم
تيجراج كايل، اأميت كومار �سينغ، ا�ض ام كوترا�سيتي، ابهي�سيك كابور
امللخ�ص: الهدف: تقييم فعالية �سماد هيمكون لالأ�سنان يف ال�سيطرة على النزيف بعد خلع ال�سن والتاأكد من دوره يف �سفاء اجلروح باملقارنة 
مع الطريقة التقليدية. الطريقة: كان جميع امل�ساركني يف الدرا�سة )وعددهم 40( يتلقون العالج امل�ساد لل�سفيحات عن طريق الفم. مت قلع 
ما جمموعه 80 من الأ�سنان دون تغيري عالج املر�سى، ومت تق�سيم مواقع القلع اإىل جمموعتني: املجموعة الأوىل عوجلت ب�سماد هيمكون، 
واملجموعة الثانية عوجلت بالطريقة التقليدية املتبعة يف ال�سغط مع �سا�ض معقم حتت �سغط الع�ض )تليها خياطة اإذا لزم الأمر( لتحقيق 
ثانية( من مواقع   53 )املتو�سط =  للدم  الهيمكون تخرثا �رسيعا  التي مت عالجها ب�سماد  القلع  النتائج: حققت جميع مواقع  الدم.  تخرث 
القلع التي عوجلت بالطريقة التقليدية )املتو�سط = 918 ثانية( وكان الفرق ذات دللة اإح�سائية معتدة )P <0.001(. كما كان الأمل بعد 
اجلراحة يف جمموعة �سماد الهيمكون )1.74( اأي�سا اأقل بكثري مما كانت عليه يف املجموعة ال�سابطة )P<0.001()5.26(. واأظهرت 
بكثري من  اأف�سل  ب�سكل  اجلراحية  العملية  بعد  لل�سفاء  الهيمكون متاثلوا  املعاجلة ب�سماد  املواقع  72.5% من  يقرب من  ما  اأن  الدرا�سة 
املوقع املعاجلة تقليديا )P <0.001(. اخلال�صة: ثبت اأن �سماد الهيمكون عامال ممتازا لتخرث الدم حيث اخت�رس كثريا من وقت نزيف 
ما بعد قلع الأ�سنان عند املر�سى الذين يتناولون الأدوية امل�سادة لل�سفيحات.  بالإ�سافة اإىل ذلك، حت�سن اللتئام بعد اجلراحة يف قلع 
الأ�سنان ب�سكل ملحوظ ، وكان الأمل اأقل كذلك.
مفتاح الكلمات: مثبطات تكد�ض ال�سفيحات، ال�سيتوزان، نزف، التئام اجلروح.
abstract: Objectives: The purpose of the study was to evaluate the effectiveness of the HemCon Dental Dressing 
(HDD) in controlling post extraction bleeding and to ascertain its role in healing of extraction wounds, as compared 
to control. Methods: The 40 participants in the study were all receiving oral antiplatelet therapy (OAT). A total 
of 80 extractions were conducted without altering the patients’ drug therapy. The extraction sites were divided 
into 2 groups: one group received a HDD, and the control group where the conventional method of pressure 
pack with sterile gauze under biting pressure (followed by suturing if required) was used to achieve haemostasis. 
Results: All HemCon treated sites achieved haemostasis sooner (mean = 53 seconds) than the control sites (mean 
= 918 seconds) which was statistically significant (P  <0.001). Postoperative pain in the HDD group (1.74) was also 
significantly lower than in the control group (5.26) (P <0.001). Approximately 72.5% of HDD-treated sites showed 
significantly better postoperative healing when compared to the control site (P <0.001). Conclusion: HDD proved 
to be an excellent haemostatic agent that significantly shortened the  bleeding  time following dental extraction in 
patients on OAT. Additionally, HDD offered significantly improved post-operative healing of the extraction socket 
and less postoperative pain.
Keywords: Platelet aggregation inhibitors; Chitosan; Hemorrhage; Wound healing.
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Advances in Knowledge
- For patients undergoing simple extractions, the study outcome supports no change in patient’s oral antiplatelet drug regimen.
- Expected results regarding the effectiveness of chitosan were observed.
- This clinical study supports the use of advances in technology (chitosan) to improve patient care. 
Application to Patient Care 
- Health professionals still prefer to alter drug regimens for patients receiving oral antiplatelet therapy (OAT) prior to minor surgical 
procedures. This places patients at risk of developing thromboembolism.
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Medical problems are one of the roadblocks for oral and maxillofacial surgeons; they are expected to manage 
patients with such ailments with utmost care.1 
Excessive bleeding in patients on oral antiplatelet 
therapy (OAT) is currently one of the most 
commonly encountered complications in dentistry, 
making OAT patients some of the most challenging 
patients to treat.2
Although the prevalence of bleeding disorders in 
patients being treated by dentists and oral surgeons 
appears to be small, a study in 1994 showed that 
2.3% of 1500 adults seeking dental treatment were 
on OAT and, indeed, bleeding disorders were 
more prevalent than cancer, renal disease, or joint 
replacement.3
When encountering such a patient, a dental 
surgeon has the choice of either altering or stopping 
the OAT, which presents a risk of thromboembolism, 
or continuing the OAT and risking uncontrolled 
bleeding.4–9 A common approach to managing such 
patients is suspension of the OAT for 3 to 4 days 
before surgery, which exposes the patients to a higher 
risk of thromboembolism, myocardial infarction, 
and cardiovascular accidents.10,11 Intraoperative or 
postoperative bleeding is not significantly reduced 
by this regimen. Other authors have suggested 
the use of local haemostatic measures to control 
intra- and postoperative bleeding without altering 
a patient’s OAT regimen.12–14 Many styptics such 
as the gelatin sponge, fibrin glue, and tranexamic 
acid have been used in the past to control intra- and 
postoperative haemorrhage.
The HemCon Dental Dressing (HDD) (HemCon 
Medical Technologies, Portland, Oregon, USA) 
is an USA Food and Drug Administration (FDA) 
approved material which has been used extensively 
under the name HemCon Bandage to stop bleeding 
in combat wounds and other severe trauma.15,16 The 
HDD is a new generation medical device which 
offers self-adhesion and provides a protective layer 
that can be custom cut according to a patient’s 
need. Although haemostasis proceeds rapidly, 
there is no heat generated that might cause thermal 
injury to the wound site.17 HDD is chitin, which 
is manufactured from freeze dried shrimp shells. 
Chitin is an insoluble polysaccharide polymer 
of glucosamine that is purified and partially 
deacetylated to form soluble chitosan aqueous 
gel.18,19 Chitosan gel is then freeze dried in moulds to 
make a highly electropositive sponge-like material 
that is haemostatic and adapts well to oral surgical 
wounds. Chitosan is a food grade material which 
can be safely ingested, and its accidental inhalation 
risk is almost zero as it undergoes dissolution.
Chitosan has a positive charge and attracts 
red blood cells (RBC) and platelets, which are 
negatively charged through ionic interaction; thus, 
a strong seal is formed at the wound site.16 This 
supportive, primary seal allows the body to activate 
its coagulation pathway effectively, initially forming 
organised platelets. HDDs are designed to maintain 
this seal and serve as a frontline support structure 
as the platelets and RBC continue to aggregate until 
haemostasis is achieved. HDDs do not rely solely on 
the clotting cascade to maintain haemostasis.20 The 
strong sealing action allows the body to form a clot 
naturally. HDD can also be used in haemophiliac 
patients as clot formation is based on electrostatic 
charge attraction instead of the normal quantities 
and functioning of clotting factors. In addition 
to providing haemostasis, HDD also offers an 
antibacterial barrier.
The purpose of this study was to evaluate the 
effectiveness of HDD in controlling post- extraction 
bleeding and its role in the healing of extraction 
wounds as compared to more conventional methods 
such as pressure gauze, followed by suturing if 
required. For our study, we hypothesised that, in 
OAT patients, HDD would yield better outcomes 
as compared to more conventional measures used 
after tooth extractions.
Methods
A total of 40 adult OAT patients undergoing 
extractions were chosen randomly for this study 
after institutional review board approval was 
- The study results showed earlier haemostasis, less discomfort, and better healing without changing a patient’s OAT regimen when 
undergoing minor surgical procedures using HDD.
- The study results also support early treatment without repeated evaluations of international normalised ratios in patients receiving 
OAT regimens.
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obtained. All patients underwent extractions 
without any alteration to their antiplatelet 
medication regimens. Included in the study 
were OAT patients undergoing multiple tooth 
extractions who were between the ages of 35 and 
75 years, and had international normalised ratio 
(INR) values ≤3 (1–3). Diabetic patients with well-
controlled sugar levels were also included. Patients 
undergoing a single tooth extraction or multiple 
extractions limited to one quadrant; those with an 
allergy to seafood; those indicating that they were 
smokers, and those with genetic bleeding disorders 
were excluded from the study.
All patients underwent various investigations 
preoperatively such as haemoglobin estimation 
(Hb), bleeding time (BT), clotting time (CT), INR, 
and platelet count (PC). BT measures the primary 
phase of haemostasis—the interaction of the blood 
vessel wall and the formation of a haemostatic plug. 
CT indicates the time interval from the formation of 
a platelet plug to the completion of vasoconstriction 
and clot formation. Similar and identical extraction 
sites were selected within each patient (for example, 
extraction of the first molars in the right and left 
quadrants of the lower jaw). A split-mouth study 
design was used. By this method, a patient would 
receive HDD on one side of the mouth (study site). 
On the other side (control side), the conventional 
method of pressure packing with a sterile piece of 
gauze under biting pressure, followed by suturing, 
if required, was used to achieve haemostasis after 
extraction. To reduce study variability, similar 
contralateral or counterpart teeth were extracted 
wherever possible (32 patients). In the other 8 
patients, similar sized teeth were selected (i.e. single 
rooted tooth for single rooted tooth and molar for 
molar). Neither the surgeon nor the patients could 
be blinded to the use of HDD versus the control 
method; however, every second patient’s left side/
upper arch was used as a study site. After obtaining 
consent, each patient underwent atraumatic simple 
extractions under local anaesthesia using lignocaine 
with adrenaline (1:80,000). The procedure was 
completed on a single visit by a single surgeon. 
Surgical sites were randomly selected for treatment 
either by a complete or custom-cut HDD in one 
quadrant and a control consisting of biting pressure 
on a sterile cotton gauze dressing followed by 
suturing if required in the other quadrant in each 
patient. Custom-cut HDDs were used to fit loosely 
into extraction sockets that were smaller than the 
size of a complete HDD (10 mm x 12 mm x 5.5 mm). 
A HDD was placed into the extraction socket at the 
height of the crestal bone wherever possible. Direct 
finger pressure was placed over the extraction 
site for 40–60 seconds after placement of the 
HDD. Sutures were placed whenever haemostasis 
was not achieved under biting pressure over the 
sterile gauze piece after 900 seconds (15 minutes). 
Timing to haemostasis was noted for both the 
HDD and control surgical sites using a stopwatch. 
All patients were prescribed a diclomol tablet 
(diclofenac sodium 50 mg + paracetamol 500 mg) 
every 8 hours for 3 days. All patients were reviewed 
by another surgeon on the 7th postoperative day 
for assessment of pain and healing. Relative pain 
scores were assessed 1 week postoperatively. 
Self-reported pain scores on a scale of 0–10 were 
taken into account to estimate postoperative pain. 
Healing was assessed on the basis of epithelization 
using the visual analogue scale, the presence of liver 
clots, pus discharge, dry socket, and the extent of 
the sinus opening. Healing was compared between 
the study and control sites and was assessed on a 
scale of 1–3 with 1 representing the healing of the 
study site being significantly worse than the control; 
2 representing the healing of the study site being 
the same as the control, and 3 meaning the healing 
Table 1: Details of patient age and various investigations (N = 40)
Variables Mean SD Minimum Maximum
Age (years) 56.2 9.61 38 74
Hb (gm %) 13.2 0.92 11.6 15.8
PC (mm3) 2,46,900 48,113 1,14,000 3,28,000
BT (seconds) 192 24 150 240
CT (seconds) 324 30 240 390
Legend: SD = standard deviation; Hb = haemoglobin estimation; PC = platelet count; BT = bleeding time; CT = clotting time.
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of the study site was significantly better than the 
control. 
Secondary bleeding was assessed through 
patients’ self-reporting and/or by the presence or 
absence of liver clots. Secondary bleeding/venous 
haemorrhage is usually characterised by the slow 
oozing of dark red blood and can manifest as liver 
clots. Liver clots, which are also known as currant 
jelly clots, are defined as red, jelly-like clots that 
are rich in haemoglobin from erythrocytes within 
the clot. Statistical analysis through a paired t-test 
and the Wilcoxon signed-rank test was applied for 
testing statistical significance. 
Results
Out of the 40 patients, there were 33 males and 7 
females. The mean BT was 192 seconds and the 
mean PC was 246,000/cc [Table 1].
HDDs that had adhered to the soft/hard tissue 
adjacent to the extraction site were easily removed 
after wetting with sterile normal saline, and 
there was no adherence to the sterile gauze piece 
used on the control site postoperatively. Time to 
haemostasis was noted for both the HDD and 
control surgical sites using a stopwatch. The study 
site achieved haemostasis at 53 seconds, which 
was a considerably shorter time than the control 
site at 918 seconds [Table 2]. There was statistically 
improved haemostasis with the use of HDD.
The postoperative pain experienced by patients 
throughout the week while performing day-to-day 
activities such as eating, tooth brushing, etc. were 
recorded as 0 being no pain and 10 being the worst 
pain the patient had ever experienced. The average 
pain score at the study site (1.74) was considerably 
less than the control site (5.26) [Table 2].
Although we did not experience any cases of liver 
clots, sinus opening, pus discharge, or dry socket, 
there was comparatively better epithelialization 
with the use of HDD. The 29 study sites showed 
significantly better healing as compared to the 
control sites [Table 2].
Discussion
Clopidogrel and ticlopidine inhibit adenosine 
diphosphate (ADP)-induced platelet fibrinogen 
binding whereas aspirin inhibits the activity of 
cyclooxygenase. Platelets are affected for the life 
of the cell, and complete reversal of antiplatelet 
activity does not occur for approximately 2 weeks. 
In this study, the HDD was used to control bleeding 
in extraction wounds in patients receiving OAT. 
The results show that in every patient the time to 
haemostasis was shorter when using HDD than 
when using the control.
Shen et al. showed a release of growth factor 
from human platelets stimulated by chitosan 
exposure, which may help explain our positive 
findings.21 Cunha-Reis et al. showed cell adhesion 
consistent with the nature of the HDD material used 
in this study.22 In our study, sites receiving the HDD 
had improved postoperative healing with minimal 
complications when compared to the control 
site. This may be attributed to the antibacterial 
properties of chitosan, which have been investigated 
in vitro studies.23,24 Results demonstrated that 
chitosan increased permeability of the inner and 
outer membranes and ultimately disrupted the 
bacterial cell membranes, releasing their contents. 
Thus HDD provides an antibacterial barrier 
against a wide range of Gram positive and Gram 
negative organisms, including methicillin-resistant 
Staphylococcus aureus (MRSA), vancomycin-
resistant enterococcus (VRE), and Acinetobacter 
baumannii.23,24 In an animal study, Azargoon et 
al. found HDD to be as efficacious ferric sulfate in 
haemostasis and wound healing.25
The self-adhesive nature of HDD is caused by 
the electrostatic attraction of RBC to the HemCon 
material. As the RBCs bind to the HDD surface, it 
forms a dense viscous mass that provides adhesion, 
and also adapts to the alveolar bone’s irregularities 
under digital pressure, thereby providing frictional 
locking with the bony socket. Considering the 
competency of HDD in forming a barrier that seals 
the wound from exposure to the environment, we 
can state that only a small amount of HDD (i.e. 
about ½ of a 10 mm x 12 mm piece) is required to 
attain complete haemostasis [Figure 1]. There was 
Table 2: Comparison of bleeding time, pain score and 
quality of healing





53 ± 13 
seconds
918 ± 769 
seconds
<0.0001
Pain score 1.74 ± 0.65 5.26 ± 1.33 <0.0001
Healing 29 0 <0.0001
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no clinical indication of the necessity to pack the 
extraction socket fully, and the excess was easily 
trimmed chair side, according to the patients’ needs. 
Additionally, we observed initial slightly raised 
pain scores in sites with HDD, which subsided once 
the acetic acid was fully dissolved in oral fluids. To 
work, HDD material requires active bleeding; thus, 
the more bleeding takes place, the better the HDD 
material performs which is quite useful during 
surgical procedures. 
Conclusion
The results of this study fully support our hypothesis 
regarding the effectiveness of HDD in patients 
receiving OAT. They show that HemCon is a new 
generation haemostatic agent which facilitates 
early haemostasis of extraction wounds, along with 
improved healing  and reduces postoperative pain.25 
The use of HDD eliminates or minimises the risk 
of thromboembolism by allowing the patient to 
continue his/her antiplatelet medication regimens; 
however, the haemostatic properties of the HDD 
do not obviate the need for thorough pre- and 
postoperative evaluation and management of a 
patient’s INR status. 
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